Skip to main content Accessibility help
×
Home

Decision Support for Re-Designed Medicinal Products - Assessing Consequences of a Customizable Product Design on the Value Chain from a Sustainability Perspective

  • Maria Siiskonen (a1), Matilda Watz (a2), Johan Malmqvist (a1) and Staffan Folestad (a3)

Abstract

Despite advances in pharmacological research providing means for individually customized patient attribute treatments, the 'one-size-fits-all' paradigm remains. Customization is associated with cost increases and the value assessment of customized medicinal products shows upon a narrow economic focus. Inspired by value models, emerging in manufacturing industry research, this study suggests a novel methodology encompassing a full sustainability perspective, including the social, economic and ecological dimension, for design decision support for medicinal products. A concept screening matrix is adapted, using sustainability criteria as value indicators. The focus is to create value for the whole pharmaceutical value chain whilst keeping the core purpose of medicinal products, i.e. to bring societal benefits. An illustrative case study presents an application of the methodology on a commercial product for curing hypertension. The traditional product design for hypertension treatment is compared to a customized product design. Results indicate that a customized product design is preferable if value is to be created from a social or/and an ecological sustainability perspective.

    • Send article to Kindle

      To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

      Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      Decision Support for Re-Designed Medicinal Products - Assessing Consequences of a Customizable Product Design on the Value Chain from a Sustainability Perspective
      Available formats
      ×

      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

      Decision Support for Re-Designed Medicinal Products - Assessing Consequences of a Customizable Product Design on the Value Chain from a Sustainability Perspective
      Available formats
      ×

      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

      Decision Support for Re-Designed Medicinal Products - Assessing Consequences of a Customizable Product Design on the Value Chain from a Sustainability Perspective
      Available formats
      ×

Copyright

This is an Open Access article, distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is unaltered and is properly cited. The written permission of Cambridge University Press must be obtained for commercial re-use or in order to create a derivative work.

Corresponding author

Contact: Siiskonen, Maria Daniela Irene, Chalmers University of Technology, Industrial and materials science, Sweden, maria.siiskonen@chalmers.se

References

Hide All
Aitken, M. (2016), “Understanding the pharmaceutical value chain”, Pharm Policy and Law, Vol. 18 No. 1–4, pp. 5566. http://doi.org/cxzc
Bertoni, M., Hallstedt, S. and Isaksson, O. (2015), “A model-based approach for sustainability and value assessment in the aerospace value chain”, Adv Mech Eng, Vol. 7 No. 6, pp. 119. http://doi.org/f3pnrf.
Broman, G.I. and Robért, K-H. (2017), “A framework for strategic sustainable development”, J Cleaner Prod, Vol. 140 No. 1, pp. 1731. https://doi.org/10.1016/j.jclepro.2015.10.121.
Claesson, A. (2006), “A Configurable Component Framework Supporting Platform-Based Product Development”, Doctoral Thesis, Department of Product and Production Development, Chalmers University of Technology, Gothenburg.
Crommelin, D.J.A., Storm, G. and Luijten, P. (2011), “‘Personalised medicine’ through ‘personalised medicines’: Time to integrate advanced, non-invasive imaging approaches and smart drug delivery systems”, Int J Pharm, Vol. 415 No. 1–2, pp. 58. http://doi.org/fr4thx.
Food and Drug Administration. (2015), Size, Shape, and Other Physical Attributes of Generic Tablets and Capsules Guidance for Industry.
Food and Drug Administration. (2018), Step 3: Clinical Research.
Goyanes, A., Martinez, P.R., Buanz, A., Basit, A.W. and Gaisford, S. (2015), “Effect of geometry on drug release from 3D printed tablets”, Int J Pharm, Vol. 494 No. 2, pp. 657663. http://doi.org/f7vm6f.
Hallstedt, S.I., Bertoni, M. and Isaksson, O. (2015), “Assessing sustainability and value of manufacturing processes: a case in the aerospace industry”, J Cleaner Prod, Vol. 108, pp. 169182. http://doi.org/f3pz7z.
Harrington, T.S., Phillips, M.A. and Srai, J.S. (2017), “Reconfiguring global pharmaceutical value networks through targeted technology interventions”, Int J Prod Res, Vol. 55 No. 5, pp. 14711487. http://doi.org/cxr7.
Hatz, M.H.M., Schremser, K. and Rogowski, W.H. (2014), “Is individualized medicine more cost-effective? a systematic review”, PharmacoEconomics, Vol. 32, No. 5, pp. 443455. http://doi.org/f53wq6.
Ho, P.M., Rumsfeld, J.S., Masoudi, F.A., McClure, D.L., Plomondon, M.E., Steiner, J.F. and Magid, D.J. (2006), “Effect of medication nonadherence on hospitalization and mortality among patients with diabetes mellitus”, Arch Intern Med, Vol. 166, pp. 18361841. http://doi.org/dwhzz4
Klingmann, V., Spomer, N., Lerch, C., Stoltenberg, I., Frömke, C., Bosse, H.M., Breitkreutz, J. and Meissner, T. (2013), “Favorable acceptance of mini-tablets compared with syrup: a randomized controlled trial in infants and preschool children”, J Pediatrics, Vol. 163, pp. 17281733. http://doi.org/f2nzbt.
Lee, S.L., O'Connor, T.F., Yang, X., Cruz, C.N., Chatterjee, S., Madurawe, R.D., Moore, C.M.V., Yu, L.X. and Woodcock, J. (2015), “Modernizing pharmaceutical manufacturing: from batch to continuous production”, J Pharm Innov, Vol. 10 No. 3, pp. 191199. http://doi.org/cxr8.
MacGill, M. (2018), Everything You Need to Know about Hypertension. Available at: https://www.medicalnewstoday.com/articles/150109.php (Accessed: 4 December 2018).
Nagashree, K. (2015), “Solid dosage forms: Tablets”, J Pharm Analysis, Vol. 4. No. 2
Nicholson Price, W. and Rai, A.K. (2015), “Manufacturing barriers to biologics competition and innovation”, Iowa Law Review.
Pugh, S. (1990), Total Design: Integrated Methods for Successful Product Engineering, Addison-Wesley, Wokingham.
Savoia, C., Volpe, M., Grassi, G., Borghi, C., Agabiti Rosei, E. and Touyz, R.M. (2017), “Personalized medicine — a modern approach for the diagnosis and management of hypertension”, Clinical Science, Vol. 131 No. 22, pp. 26712685. http://doi.org/cxr9.
Segawa, A., Yoshikawa, S., Toyama, T., Nakanishi, H., Kikuchi-Uehara, E., Hirao, M. and Sugiyama, H. (2016), “Method for reducing environmental, health, and safety risks in active pharmaceutical ingredient manufacturing based on multiobjective evaluation”, Process Safety and Environmental Protection, Vol. 104, pp. 304313. http://doi.org/cxsb.
Sheldon, R.A. (2016), “Green chemistry and resource efficiency: towards a green economy”, Green Chem, Vol. 18 pp. 31803183. http://doi.org/cxsc.
Siiskonen, M., Folestad, S. and Malmqvist, J. (2018), “Applying function-means tree modelling to personalized medicines”, In Proceedings of NordDesign 2018, Linköping, 14th–17th August 2018
Slater, C.S., Savelski, M.J. and Ruiz-Felix, M.N. (2013), “Life cycle analysis of solvent reduction in pharmaceutical synthesis using continuous adsorption for palladium removal”, J Env Sci Health, Part A, Vol. 48 No. 13, pp. 16021608. http://doi.org/cxsd.
Slater, C.S. and Savelski, M. (2007), “A method to characterize the greenness of solvents used in pharmaceutical manufacture”, J Env Sci Health, Part A, Vol. 42 No. 11, pp. 15951605. http://doi.org/bg2hjh.
Srai, J.S., Harrington, T., Alinaghian, L. and Phillips, M. (2015), “Evaluating the potential for the continuous processing of pharmaceutical products-a supply network perspective”, Chem Eng and Proc, Vol. 97, pp. 248258. http://doi.org/f7z2t6.
Ulrich, Karl T and Eppinger, S. D. (2012), Product Design and Development, McGraw-Hill, New York.
Unger, C. (2013), Yttrande över Miljömålsberedningens delbetänkande “Minska riskerna med farliga ämnen” (SOU 2012:38) samt Kemikalie-inspektionens rapporter “Bättre EU-regler för en giftfri miljö” och “Handlingsplan för en giftfri vardag – förslag till åtgärder”, (Opinion on Environmental objectives council's interim report “Reduce risks of dangerous substances” (SOU 2012:38) and Swedish Chemicals Agency's reports “Better EU-rules for a non-toxic environment” and “Action plan for a non-toxic living - suggestions for actions”), In Swedish.
Villamil, C., Nylander, J., Hallstedt, S.I., Schulte, J. and Watz, M. (2018), “Additive Manufacturing from a Strategic Sustainability Perspective”, In Proceedings of the DESIGN 2018 15th International Design Conference, Dubrovnik, 21st–24th May 2018, pp. 13811392.

Keywords

Decision Support for Re-Designed Medicinal Products - Assessing Consequences of a Customizable Product Design on the Value Chain from a Sustainability Perspective

  • Maria Siiskonen (a1), Matilda Watz (a2), Johan Malmqvist (a1) and Staffan Folestad (a3)

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed